Latest Development Approvals News

Eureka Group Holdings delivered FY26 underlying earnings ahead of guidance as its all-age rental portfolio expanded rapidly, but statutory profit fell and borrowings more than doubled. The next test is whether acquisitions, development and new capital partnerships can convert scale into durable cash returns.

Ark Mines has reported a FY2026 profit after receiving Queensland-backed funding, while its Sandy Mitchell rare earths resource expanded to 379.4 million tonnes after year end. The project now has development approvals and commercial-grade testwork behind it, but no Ore Reserve or mining decision yet.

Parkway Corporate Limited (ASX:PWN) delivered a sharp revenue increase in FY26 and generated positive operating cash flow, but slipped into a statutory loss and flagged significant uncertainty around its ability to continue as a going concern. Key approvals for its Queensland brine project and a new $2 million mining contract offer commercial progress, while funding remains the central test.

Desane Group Holdings reported a sharp FY26 profit decline as lower property revaluation gains and higher finance costs overwhelmed largely stable rental income. The ASX-listed property group enters FY27 with more cash, conservative gearing and two developments that now need to convert asset value into earnings.

Argent BioPharma has secured exclusive commercialisation rights to selected Tollovir, Tollovid and NutraVir antiviral products in a worldwide deal excluding China. The agreement adds a new commercial pillar alongside CimetrA®, but does not itself grant pharmaceutical development rights or establish clinical efficacy.

Australian Vanadium reported progress across its mine, electrolyte and battery businesses, but auditors highlighted material uncertainty over the company’s ability to continue as a going concern. The group held $17.9 million in cash at 30 June, yet expects to need additional funding within 12 months.

Silver Mines has secured firm commitments for a $70 million placement, giving the company more funding to advance its Bowdens Silver Project through development approvals and engineering studies. The raise also supports royalty acquisitions, exploration and land access, although nearly 43% of the new shares still require shareholder approval.

Delorean Corporation and Opal have completed the concept stage for a proposed anaerobic digestion facility at Opal’s Maryvale Mill in Victoria. The project could replace natural gas used by the mill’s rotary lime kiln, but still requires further engineering, commercial work and a final investment decision.

Harmoney will continue buying back up to 5% of its issued shares while reaffirming FY27 cash NPAT guidance of $16 million or more. The lender also says potential acquisitions could be funded without an equity raising, although no transaction has been announced.

Sky Metals has used FY2026 to move Tallebung from exploration toward development, combining more than 500 drill holes with strong ore-sorting results and progress into NSW’s environmental approval process. The advance came alongside a A$5.37 million loss and continuing reliance on equity funding.

Vicinity Centres used its 2026 Capability Showcase to make the case for a more concentrated, premium retail portfolio, led by Chadstone and Chatswood Chase. The presentation also set out development returns, balance-sheet capacity and a sizeable residential option beside Chatswood Chase, although much of the value remains dependent on stabilisation, approvals and market conditions.

Vicinity Centres has positioned portfolio premiumisation and development execution as the engine of future growth, but its Chadstone case study also shows how quickly valuation assumptions can alter project returns. The company highlighted a potential residential expansion at Chatswood Chase alongside strong occupancy, modest gearing and a large development pipeline.